{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:18:59Z","timestamp":1791037139182,"version":"4.1.0"},"reference-count":15,"publisher":"American Association for Cancer Research (AACR)","issue":"12","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We recently showed that a subset of human T acute lymphoblastic leukemia (T-ALL) cell lines expresses low basal levels of p50, a nuclear factor-\u03baB (NF-\u03baB)\/Rel family member, resulting in their capacity to activate the atypical p65:cRel complex rather than the classic p50:p65 dimer. Here, we show that the transcription factor TAL1 (also known as SCL) binds to the promoter of the NFKB1 gene that encodes p50 and represses its transcription to set up this unique response in T-ALL cells. When TAL1 expression is reduced in CEM T leukemia cells, basal NFKB1 expression is increased, and the levels of p65:cRel complex and transcription of its target gene, such as intercellular adhesion molecule-1 (ICAM-1), are reduced in response to etoposide treatment. Moreover, a significant negative correlation between NFKB1 and TAL1 or LMO1 was found in primary human TAL1\/LMO1 double-positive T-ALL samples previously described by Ferrando et al. Thus, TAL1 modulates NFKB1 expression and an NF-\u03baB-dependent transcriptional program in a subset of human T-cell leukemia cells. (Cancer Res 2006; 66(12): 6008-13)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-0194","type":"journal-article","created":{"date-parts":[[2006,6,15]],"date-time":"2006-06-15T17:49:25Z","timestamp":1150393765000},"page":"6008-6013","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["NFKB1 Is a Direct Target of the TAL1 Oncoprotein in Human T Leukemia Cells"],"prefix":"10.1158","volume":"66","author":[{"given":"Pei-Yun","family":"Chang","sequence":"first","affiliation":[{"name":"1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin-Madison, Madison, Wisconsin and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Draheim","sequence":"additional","affiliation":[{"name":"2Department of Cancer Biology and the Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Kelliher","sequence":"additional","affiliation":[{"name":"2Department of Cancer Biology and the Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin-Madison, Madison, Wisconsin and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,6,15]]},"reference":[{"key":"2022061622121807000_B1","doi-asserted-by":"crossref","unstructured":"Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH. The T cell leukemia oncoprotein SCL\/tal-1 is essential for development of all hematopoietic lineages. Cell\u20081996; 86: 47\u201357.","DOI":"10.1016\/S0092-8674(00)80076-8"},{"key":"2022061622121807000_B2","doi-asserted-by":"crossref","unstructured":"Tremblay M, Herblot S, Lecuyer E, Hoang T. Regulation of pT alpha gene expression by a dosage of E2A, HEB, SCL. J Biol Chem\u20082003; 278: 12680\u20137.","DOI":"10.1074\/jbc.M209870200"},{"key":"2022061622121807000_B3","doi-asserted-by":"crossref","unstructured":"O'Neil J, Shank J, Cusson N, Murre C, Kelliher M. TAL1\/SCL induces leukemia by inhibiting the transcriptional activity of E47\/HEB. Cancer Cell\u20082004; 5: 587\u201396.","DOI":"10.1016\/j.ccr.2004.05.023"},{"key":"2022061622121807000_B4","doi-asserted-by":"crossref","unstructured":"Talora C, Cialfi S, Oliviero C, et al. Cross-talk among Notch3, pre-TCR and Tal-1 in T-cell development and leukemogenesis. Blood\u20082006; 107: 3313\u201320.","DOI":"10.1182\/blood-2005-07-2823"},{"key":"2022061622121807000_B5","doi-asserted-by":"crossref","unstructured":"Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell\u20082002; 1: 75\u201387.","DOI":"10.1016\/S1535-6108(02)00018-1"},{"key":"2022061622121807000_B6","doi-asserted-by":"crossref","unstructured":"Chang PY, Miyamoto S. Nuclear factor-kappaB dimer exchange promotes a p21(waf1\/cip1) superinduction response in human T leukemic cells. Mol Cancer Res\u20082006; 4: 101\u201312.","DOI":"10.1158\/1541-7786.MCR-05-0259"},{"key":"2022061622121807000_B7","doi-asserted-by":"crossref","unstructured":"Wissink S, van de Stolpe A, Caldenhoven E, Koenderman L, van der Saag PT. NF-kappa B\/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. Immunobiology\u20081997; 198: 50\u201364.","DOI":"10.1016\/S0171-2985(97)80026-5"},{"key":"2022061622121807000_B8","doi-asserted-by":"crossref","unstructured":"Krosl G, He G, Lefrancois M, et al. Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. J Exp Med\u20081998; 188: 439\u201350.","DOI":"10.1084\/jem.188.3.439"},{"key":"2022061622121807000_B9","doi-asserted-by":"crossref","unstructured":"Kelliher MA, Seldin DC, Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J\u20081996; 15: 5160\u20136.","DOI":"10.1002\/j.1460-2075.1996.tb00900.x"},{"key":"2022061622121807000_B10","doi-asserted-by":"crossref","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature\u20082000; 403: 503\u201311.","DOI":"10.1038\/35000501"},{"key":"2022061622121807000_B11","doi-asserted-by":"crossref","unstructured":"Li Z, Wang X, Yu RY, et al. BCL-6 negatively regulates expression of the NF-kappaB1 p105\/p50 subunit. J Immunol\u20082005; 174: 205\u201314.","DOI":"10.4049\/jimmunol.174.1.205"},{"key":"2022061622121807000_B12","doi-asserted-by":"crossref","unstructured":"Otsuki T, Yano T, Clark HM, et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas:results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood\u20081995; 85: 2877\u201384.","DOI":"10.1182\/blood.V85.10.2877.bloodjournal85102877"},{"key":"2022061622121807000_B13","doi-asserted-by":"crossref","unstructured":"Bernard M, Delabesse E, Smit L, et al. Helix-loop-helix (E2\u20135, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers. Int Immunol\u20081998; 10: 1539\u201349.","DOI":"10.1093\/intimm\/10.10.1539"},{"key":"2022061622121807000_B14","doi-asserted-by":"crossref","unstructured":"Schlaeger TM, Schuh A, Flitter S, et al. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL\/Tal-1. Mol Cell Biol\u20082004; 24: 7491\u2013502.","DOI":"10.1128\/MCB.24.17.7491-7502.2004"},{"key":"2022061622121807000_B15","doi-asserted-by":"crossref","unstructured":"Aggarwal BB. Nuclear factor-kappaB:the enemy within. Cancer Cell\u20082004; 6: 203\u20138.","DOI":"10.1016\/j.ccr.2004.09.003"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/12\/6008\/2864057\/6008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/12\/6008\/2864057\/6008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T20:12:05Z","timestamp":1655410325000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/12\/6008\/525939\/NFKB1-Is-a-Direct-Target-of-the-TAL1-Oncoprotein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,15]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2006,6,15]]},"published-print":{"date-parts":[[2006,6,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-0194","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22364852.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22364852","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494396","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494396.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,15]]}}}